Abstract:AIM:Point mutation, one of the commonest gene mutations, is the most important molecular pathogenesis of cancer and chronic infection. The commonest methods for detection of point mutation are based on polymerase chain reaction (PCR). These techniques, however, cannot be used in large scale screening since they are neither accurate nor simple. For this reason, this study established a novel method of competitively differentiated PCR (CD-PCR) for screening point mutation in clinical practice.METHODS:Two competitively differentiated primers for mutant-type and wild-type templates respectively with an identically complemented region in 3' end except for last 2 base pairs and a different non-complemented region in 5' end were designed. Thus, competitive amplification might be carried out at a lower annealing temperature at first, and then differentiated amplification at a higher annealing temperature when primers could not combine with initial templates. The amplification was performed in one-tube. The products of CD-PCR were detected using microplate hybridization assay. CD-PCR was evaluated by detecting G1896A variant of hepatitis B virus (HBV) in form of recombinant plasmids and in sera from patients with hepatitis B, and compared with allele-specific PCR (AS-PCR) and competitive AS-PCR.RESULTS:CD-PCR was successfully established. It could clearly distinguish wild-type and mutant-type plasmid DNA of G1896A variant when the amount of plasmid DNA was between 10(2)-10(8)copies/reaction, while for AS-PCR and competitive AS-PCR, the DNA amount was between 10(2)-10(4)copies/reaction. CD-PCR could detect one copy of G1896A variant among 10-100 copies of wild-type plasmid DNA. The specificity of CD-PCR was higher than those of AS-PCR and competitive AS-PCR in the detection of HBV G1896A variant in sera from patients with hepatitis B. CD-PCR was independent of the amount of HBV DNA in serum. HBV G1896A variant was more often found in HBeAg (-) patients with a lower level of detectable viremia than that with a higher level of detectable viremia (P=0.0192).CONCLUSION:CD-PCR is more specific since it is less influenced by the amount of initial templates and the cross amplification between mutant- and wild-type amplified products. It is also simple and time-saving. Thus, CD-PCR might be useful in routine gene typing and point mutation screening. HBV G1896A or other more important mutations have to be routinely detected in patients with a detectable level of viremia after HBeAg/antibody conversion in clinical practice.

Generation of Non-homologous Competitor DNA for Competitive Q uantitative PCR

Development of a competitive quantitative PCR assay for detecting goose circovirus DNA

[Reverse transcriptase PCR (RT-PCR) and quantitative-competitive PCR (QC-PCR)]

A Novel Real-Time Quantitative Pcr Method Using Attached Universal Template Probe

A Novel Helper Qpcr Assay for the Detection of Mirna Using Target/Helper Template for Primer Formation

A PCR Primer Bank for Quantitative Gene Expression Analysis.

[Development of EV71, CA16 and Other Enterovirus Vrial Real-Time Qualitative PCR Diagnostic Kit].

Recent Advance in Digital PCR

Application of Method to Eliminate the Heteroduplex Caused in the Course of PCR to Microbial Molecular Ecology

Thermodynamics and kinetics guided probe design for uniformly sensitive and specific DNA hybridization without optimization

Designing a Hybrid Chain Reaction Probe for Multiplex Transcripts Assay with High-Level Imaging

Methodological Improvement for PCR Amplification of the C/E1 Region in HCV Genome

Quantitative analysis of RNA by HPLC and evaluation of RT-dPCR for coronavirus RNA quantification

Highly Sensitive Enrichment of Low-Frequency Variants by Hairpin Competition Amplification

Advancing quantitative PCR with color cycle multiplex amplification

Accurate quantification of DNA using on-site PCR (osPCR) by characterizing DNA amplification at single-molecule resolution

Hydrogel-compartmentalized Heterogeneous Amplification for Viral Digital Genotyping

Information theory-based algorithm for in silico prediction of PCR products with whole genomic sequences as templates

Development of High-Resolution Melting Analysis with Unlabeled Probe for the Detection of Codon H520Q Mutation in the UL97 Gene of Human Cytomegalovirus

Novel Assay of Competitively Differentiated Polymerase Chain Reaction for Screening Point Mutation of Hepatitis B Virus.

A Novel Multiplex Fluorescent Competitive PCR for Copy Number Variation Detection.